Proxy Results Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The stockholders of CorMedix Inc. (the "Company") approved Amendment No. 1 (the "Plan Amendment") to the Amended and Restated CorMedix Inc. 2019 Omnibus Stock Incentive Plan (as amended, the "Omnibus Stock Incentive Plan") at the Company's annual meeting of stockholders (the "2024 Annual Meeting"). The Company's stockholders approved the Plan Amendment in accordance with the voting results set forth below under Item 5.07. The Plan Amendment was previously adopted by the Company's Board of Directors, subject to shareholder approval.

The material terms of the Plan Amendment were described in the Company's Proxy Statement (the "Proxy Statement") filed with the Securities and Exchange Commission on October 8, 2024, under the caption "Proposal 3 - Approval of Amendment to Amended and Restated 2019 Omnibus Stock Incentive Plan". The Plan Amendment authorizes an increase in the number of shares of the Company's common stock that are available for issuance pursuant to the Omnibus Stock Incentive Plan, as more fully described in the Proxy Statement.

The above description of the Plan Amendment does not purport to be complete and is qualified in its entirety by the full text of the Plan Amendment, set forth in Exhibit 10.1, and incorporated herein by reference.